Kaposi's Sarcoma (Therapy)
"A Multicenter, Phase II/III Study of Atragen(TM) (Tretinoin Liposomal) in Patients with AIDS Associated Kaposi's Sarcoma."
Published in Cancer Weekly, August 18th, 1997
According to an abstract submitted by the authors to the 1st National AIDS Malignancy Conference, held April 28-30, 1997, in Bethesda, Maryland, "Background: Kaposi's sarcoma (KS) is the most common malignancy associated with HIV infection. Treatment options are limited by the immunocompromised status of these patients. Chemotherapy is not well-tolerated in this group of individuals. Retinoids have been shown to be effective treatment for several skin diseases, including Kaposi's sarcoma. In an effort to achieve palliation in this patient population, we initiated a phase I/II study with AtragenTM, a liposomal formulation of all transretinoic acid. Methods: We...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1997-08-18)
More Articles from Cancer Weekly
- Cancer Vaccines (Clinical Trial)
Active Immunization with IL-2-Transduced Allogeneic Melanoma Cells - Breast Cancer
Breast Cancer is No. 1 Cause of Cancer-Related Deaths in African Women - Breast Cancer
Delegation Joined 650 People from 54 Countries for World Cancer Conference - Breast Cancer (Risk Factors)
Increased Rates in Hawaii may be Linked to Pesticides - Breast Cancer (Risk Factors)
Patients Have No Extra Risk from Pregnancy - Breast Cancer (TSG101Gene)
Second Look Acquits Gene Of Role In Breast Cancer - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
